647
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Phytocannabinoids - An Overview of the Analytical Methodologies for Detection and Quantification of Therapeutically and Recreationally Relevant Cannabis Compounds

ORCID Icon, ORCID Icon, ORCID Icon, , &
Pages 211-231 | Published online: 30 Jul 2021

References

  • Long, T.; Wagner, M.; Demske, D.; Leipe, C.; Tarasov, P. E. Cannabis in Eurasia: Origin of Human Use and Bronze Age Trans-Continental Connections. Veget. Hist. Archaeobot. 2017, 26, 245–258. DOI: 10.1007/s00334-016-0579-6.
  • Hillig, K. W. Genetic Evidence for Speciation in Cannabis (Cannabaceae). Genet. Resour. Crop Evol. 2005, 52, 161–180. DOI: 10.1007/s10722-003-4452-y.
  • Salentijn, E. M. J.; Zhang, Q.; Amaducci, S.; Yang, M.; Trindade, L. M. New Developments in Fiber Hemp (Cannabis Sativa L.) Breeding. Ind. Crops Prod. 2015, 68, 32–41. DOI: 10.1016/j.indcrop.2014.08.011.
  • Beutler, J. A.; Marderosian, A. H. Chemotaxonomy of Cannabis I. Crossbreeding between Cannabis Sativa and C. Ruderalis, with Analysis of Cannabinoid Content. Econ. Bot. 1978, 32, 387–394. DOI: 10.1007/BF02907934.
  • Mold, A. Cannabis; Getting High: Marijuana through the Ages. Cult. Soc. Hist. 2017, 0038, 1–2. DOI: 10.1080/14780038.2017.1415040..
  • Andre, C. M.; Hausman, J. F.; Guerriero, G. Cannabis Sativa: The Plant of the Thousand and One Molecules. Front. Plant. Sci. 2016, 7, 19. DOI: 10.3389/fpls.2016.00019.
  • Campbell, S.; Paquin, D.; Awaya, J. D.; Li, Q. X. Remediation of Benzo[a]Pyrene and Chrysene-Contaminated Soil with Industrial Hemp (Cannabis Sativa). Int. J. Phytoremediation. 2002, 4, 157–168. DOI: 10.1080/15226510208500080.
  • O'Connell, B. K.; Gloss, D.; Devinsky, O. Cannabinoids in Treatment-Resistant Epilepsy: A Review. Epilepsy Behav. 2017, 70, 341–348. DOI: 10.1016/j.yebeh.2016.11.012.
  • Wade, D. T.; Makela, P.; Robson, P.; House, H.; Bateman, C. Do Cannabis-Based Medicinal Extracts Have General or Specific Effects on Symptoms in Multiple Sclerosis? A Double-Blind, Randomized, Placebo-Controlled Study on 160 Patients. Mult. Scler. 2004, 10, 434–441. DOI: 10.1191/1352458504ms1082oa.
  • Manzanares, J.; Julian, M.; Carrascosa, A. Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes. Curr. Neuropharmacol. 2006, 4, 239–257. DOI: 10.2174/157015906778019527.
  • Hirst, R. A.; Lambert, D. G.; Notcutt, W. G. Pharmacology and Potential Therapeutic Uses of Cannabis. Br. J. Anaesth. 1998, 81, 77–84. DOI: 10.1093/bja/81.1.77.
  • Cho, C. M.; Hirsch, R.; Johnstone, S. General and Oral Health Implications of Cannabis Use. Aust. Dent. J. 2005, 50, 70–74. DOI: 10.1111/j.1834-7819.2005.tb00343.x.
  • Mikuriya, T. H. Marijuana in Medicine: Past, Present and Future. Calif. Med. 1969, 110, 34–40.
  • Tomida, I.; Pertwee, R. G.; Azuara-Blanco, A. Cannabinoids and Glaucoma. Br. J. Ophthalmol. 2004, 88, 708–713. DOI: 10.1136/bjo.2003.032250.
  • Moore, C.; Rana, S.; Coulter, C. Simultaneous Identification of 2-Carboxy-Tetrahydrocannabinol, Tetrahydrocannabinol, Cannabinol and Cannabidiol in Oral Fluid. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852, 459–464. DOI: 10.1016/j.jchromb.2007.02.016.
  • Borodovsky, J. T.; Crosier, B. S.; Lee, D. C.; Sargent, J. D.; Budney, A. J. Smoking, Vaping, Eating: Is Legalization Impacting the Way People Use Cannabis? Int. J. Drug Policy 2016, 36, 141–147. DOI: 10.1016/j.drugpo.2016.02.022.
  • Woolridge, E.; Barton, S.; Samuel, J.; Osorio, J.; Dougherty, A.; Holdcroft, A. Cannabis Use in HIV for Pain and Other Medical Symptoms. J. Pain Symptom Manage. 2005, 29, 358–367. DOI: 10.1016/j.jpainsymman.2004.07.011.
  • Carter, G. T.; Abood, M. E.; Aggarwal, S. K.; Weiss, M. D. Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials. Am. J. Hosp. Palliat. Care. 2010, 27, 347–356. DOI: 10.1177/1049909110369531.
  • Nagarkatti, P.; Pandey, R.; Rieder, S. A.; Hegde, V. L.; Nagarkatti, M. Cannabinoids as Novel anti-Inflammatory Drugs. Future Med. Chem. 2009, 1, 1333–1349. DOI: 10.4155/fmc.09.93.
  • Gowran, A.; Noonan, J.; Campbell, V. A. The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. CNS Neurosci. Ther. 2011, 17, 637–644. DOI: 10.1111/j.1755-5949.2010.00195.x.
  • Roitman, P.; Mechoulam, R.; Cooper-Kazaz, R.; Shalev, A. Preliminary, Open-Label, Pilot Study of Add-on Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder. Clin. Drug Investig. 2014, 34, 587–591. DOI: 10.1007/s40261-014-0212-3.
  • Aharonovich, E.; Garawi, F.; Bisaga, A.; Brooks, D.; Raby, W. N.; Rubin, E.; Nunes, E. V.; Levin, F. R. Concurrent Cannabis Use during Treatment for Comorbid ADHD and Cocaine Dependence: Effects on Outcome. Am. J. Drug Alcohol. Abuse. 2006, 32, 629–635. DOI: 10.1080/00952990600919005.
  • Reiman, A. Cannabis as a Substitute for Alcohol and Other Drugs. Harm. Reduct. J. 2009, 6, 35–35. DOI: 10.1186/1477-7517-6-35.
  • Lucas, P. Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain. J. Psychoactive Drugs 2012, 44, 125–133. DOI: 10.1080/02791072.2012.684624.
  • Swartz, R. Medical Marijuana Users in Substance Abuse Treatment. Harm. Reduct. J. 2010, 7, 3–9. DOI: 10.1186/1477-7517-7-3.
  • Mechoulam, R.; Hanuš, L. O.; Pertwee, R.; Howlett, A. C. Early Phytocannabinoid Chemistry to Endocannabinoids and Beyond. Nat. Rev. Neurosci. 2014, 15, 757–764. DOI: 10.1038/nrn3811.
  • Moreira, F. A.; Grieb, M.; Lutz, B. Central Side-Effects of Therapies Based on CB1 Cannabinoid Receptor Agonists and Antagonists: Focus on Anxiety and Depression. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23, 133–144. DOI: 10.1016/j.beem.2008.09.003.
  • Lande, A. The Single Convention on Narcotic Drugs, 1961. Int. Org. 1962, 16, 776–797. DOI: 10.1017/S0020818300011620.
  • Elsohly, M. A. Marijuana and the Cannabinoids. Humana Press Inc.: New Jersey, 2007. Vol. 1, pp 78–94.
  • Fišar, Z. Phytocannabinoids and Endocannabinoids. Curr. Drug Abuse Rev 2009, 2, 51–75. DOI: 10.2174/1874473710902010051..
  • Turcotte, C.; Blanchet, M. R.; Laviolette, M.; Flamand, N. Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs. Front. Pharmacol. 2016, 7, 317–319. DOI: 10.3389/fphar.2016.00317.
  • Mechoulam, R. Plant Cannabinoids: A Neglected Pharmacological Treasure Trove. Br. J. Pharmacol. 2005, 146, 913–915. DOI: 10.1038/sj.bjp.0706415.
  • Hudson, S.; Ramsey, J. The Emergence and Analysis of Synthetic Cannabinoids. Drug Test Anal. 2011, 3, 466–478. DOI: 10.1002/dta.268.
  • Antoniou, T.; Juurlink, D. N. Synthetic Cannabinoids. CMAJ 2014, 186, 210. DOI: 10.1503/cmaj.130510.
  • Gertsch, J.; Pertwee, R. G.; Di Marzo, V. Phytocannabinoids beyond the Cannabis Plant - Do They Exist? Br. J. Pharmacol. 2010, 160, 523–529. DOI: 10.1111/j.1476-5381.2010.00745.x.
  • Gonçalves, J.; Rosado, T.; Soares, S.; Simão, A.; Caramelo, D.; Luís, Â.; Fernández, N.; Barroso, M.; Gallardo, E.; Duarte, A. Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs. Toxicol. Aspects Anal. Deter. Med. 2019, 6, 31. DOI: 10.3390/medicines6010031.
  • Hartsel, J. A.; Eades, J.; Hickory, B.; Makriyannis, A. Neutraceuticals, Cannabis Sativa and Hemp; Chapter 53, 735-750, Elsevier Inc.: Amsterdam, The Netherlands, 2016. DOI: 10.1016/B978-0-12-802147-7.00053-X.
  • Russo, E. B. Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects. Br. J. Pharmacol. 2011, 163, 1344–1364. DOI: 10.1111/j.1476-5381.2011.01238.x.
  • Berman, P.; Futoran, K.; Lewitus, G. M.; Mukha, D.; Benami, M.; Shlomi, T.; Meiri, D. A New ESI-LC/MS Approach for Comprehensive Metabolic Profiling of Phytocannabinoids in Cannabis. Sci. Rep. 2018, Volume 8, 1–15. DOI: 10.1038/s41598-018-32651-4.
  • Lee, S. S.; Lim, J. E.; El-Azeem, S. A. M. A.; Choi, B.; Oh, S. E.; Moon, D. H.; Ok, Y. S. Heavy Metal Immobilization in Soil near Abandoned Mines Using Eggshell Waste and Rapeseed Residue. Environ. Sci. Pollut. Res. Int. 2013, 20, 1719–1726. DOI: 10.1007/s11356-012-1104-9.
  • Osland, A.; Osland, J. Book Review: Book Review. Organ. Stud. 2011, 32, 451–454. DOI: 10.1177/0170840611400272.
  • Hanuš, L. O.; Meyer, S. M.; Muñoz, E.; Taglialatela-Scafati, O.; Appendino, G. Phytocannabinoids: A Unified Critical Inventory. Nat. Prod. Rep. 2016, 33, 1357–1392. DOI: 10.1039/c6np00074f.
  • Ocque, A. J.; Hagler, C. E.; DiFrancesco, R.; Lombardo, J.; Morse, G. D. Development and Validation of an Assay to Measure Cannabidiol and Δ9-Tetrahydrocannabinol in Human EDTA Plasma by UHPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2019, 1112, 56–60. DOI: 10.1016/j.jchromb.2019.03.002.
  • Franco, R.; Rivas-Santisteban, R.; Reyes-Resina, I.; Casanovas, M.; Pérez-Olives, C.; Ferreiro-Vera, C.; Navarro, G.; Sánchez de Medina, V.; Nadal, X. Pharmacological Potential of Varinic-, Minor-, and Acidic Phytocannabinoids. Pharmacol. Res. 2020, 158, 104801. DOI: 10.1016/j.phrs.2020.104801.
  • Wargent, E. T.; Zaibi, M. S.; Silvestri, C.; Hislop, D. C.; Stocker, C. J.; Stott, C. G.; Guy, G. W.; Duncan, M.; Di Marzo, V.; Cawthorne, M. A. The Cannabinoid Δ(9)-Tetrahydrocannabivarin (THCV) Ameliorates Insulin Sensitivity in Two Mouse Models of Obesity. Nutr. Diabetes. 2013, 3, e68. DOI: 10.1038/nutd.2013.9.
  • Hill, A. J.; Weston, S. E.; Jones, N. A.; Smith, I.; Bevan, S. A.; Williamson, E. M.; Stephens, G. J.; Williams, C. M.; Whalley, B. J. Δ⁹-Tetrahydrocannabivarin Suppresses in vitro Epileptiform and in Vivo Seizure Activity in Adult Rats. Epilepsia 2010, 51, 1522–1532. DOI: 10.1111/j.1528-1167.2010.02523.x.
  • Hill, A. J.; Mercier, M. S.; Hill, T. D. M.; Glyn, S. E.; Jones, N. A.; Yamasaki, Y.; Futamura, T.; Duncan, M.; Stott, C. G.; Stephens, G. J.; et al. Cannabidivarin is Anticonvulsant in Mouse and Rat. Br. J. Pharmacol. 2012, 167, 1629–1642. DOI: 10.1111/j.1476-5381.2012.02207.x.
  • Iwata, N.; Kitanaka, S. New Cannabinoid-like Chromane and Chromene Derivatives from Rhododendron Anthopogonoides. Chem. Pharm. Bull. (Tokyo) 2011, 59, 1409–1412. DOI: 10.1248/cpb.59.1409.
  • Lourens, A. C. U.; Viljoen, A. M.; van Heerden, F. R. South African Helichrysum Species: A Review of the Traditional Uses, Biological Activity and Phytochemistry. J. Ethnopharmacol. 2008, 119, 630–652. DOI: 10.1016/j.jep.2008.06.011.
  • Pollastro, F.; De Petrocellis, L.; Schiano-Moriello, A.; Chianese, G.; Heyman, H.; Appendino, G.; Taglialatela-Scafati, O. Amorfrutin-Type Phytocannabinoids from Helichrysum Umbraculigerum. Fitoterapia 2017, 123, 13–17. DOI: 10.1016/j.fitote.2017.09.010.
  • Gardner, E. L.; Lowinson, J. H. Marijuana’s Interaction with Brain Reward Systems: Update 1991. Pharmacol. Biochem. Behav. 1991, 40, 571–580. DOI: 10.1016/0091-3057(91)90365-9.
  • Weizman, L.; Dayan, L.; Brill, S.; Nahman-Averbuch, H.; Hendler, T.; Jacob, G.; Sharon, H. Cannabis Analgesia in Chronic Neuropathic Pain is Associated with Altered Brain Connectivity. Neurology 2018, 91, e1285–e1294. DOI: 10.1212/WNL.0000000000006293.
  • DeLong, G. T.; Wolf, C. E.; Poklis, A.; Lichtman, A. H. Pharmacological Evaluation of the Natural Constituent of Cannabis Sativa, Cannabichromene and Its Modulation by Δ(9)-tetrahydrocannabinol. Drug Alcohol. Depend. 2010, 112, 126–133. DOI: 10.1016/j.drugalcdep.2010.05.019.
  • Hampson, A. J.; Grimaldi, M.; Axelrod, J.; Wink, D. Cannabidiol and (-)Delta9-Tetrahydrocannabinol Are Neuroprotective Antioxidants . Proc. Natl. Acad. Sci. U S A. 1998, 95, 8268–8273. DOI: 10.1073/pnas.95.14.8268.
  • Morimoto, S.; Tanaka, Y.; Sasaki, K.; Tanaka, H.; Fukamizu, T.; Shoyama, Y.; Shoyama, Y.; Taura, F. Identification and Characterization of Cannabinoids That Induce Cell Death through Mitochondrial Permeability Transition in Cannabis Leaf Cells. J. Biol. Chem. 2007, 282, 20739–20751. DOI: 10.1074/jbc.M700133200.
  • Appendino, G.; Gibbons, S.; Giana, A.; Pagani, A.; Grassi, G.; Stavri, M.; Smith, E.; Rahman, M. M. Antibacterial Cannabinoids from Cannabis Sativa: A Structure-Activity Study. J. Nat. Prod. 2008, 71, 1427–1430. DOI: 10.1021/np8002673.
  • Wilkinson, J. D.; Williamson, E. M. Cannabinoids Inhibit Human Keratinocyte Proliferation through a Non-CB1/CB2 Mechanism and Have a Potential Therapeutic Value in the Treatment of Psoriasis. J. Dermatol. Sci. 2007, 45, 87–92. DOI: 10.1016/j.jdermsci.2006.10.009.
  • Ligresti, A.; Moriello, A. S.; Starowicz, K.; Matias, I.; Pisanti, S.; De Petrocellis, L.; Laezza, C.; Portella, G.; Bifulco, M.; Di Marzo, V. Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma. J. Pharmacol. Exp. Ther. 2006, 318, 1375–1387. DOI: 10.1124/jpet.106.105247.
  • Maione, S.; Piscitelli, F.; Gatta, L.; Vita, D.; De Petrocellis, L.; Palazzo, E.; De Novellis, V.; Di Marzo, V. Non-Psychoactive Cannabinoids Modulate the Descending Pathway of Antinociception in Anaesthetized Rats through Several Mechanisms of Action. Br. J. Pharmacol. 2011, 162, 584–596. DOI: 10.1111/j.1476-5381.2010.01063.x.
  • Fusar-Poli, P.; Allen, P.; Bhattacharyya, S.; Crippa, J. A.; Mechelli, A.; Borgwardt, S.; Martin-Santos, R.; Seal, M. L.; O'Carrol, C.; Atakan, Z.; et al. Modulation of Effective Connectivity during Emotional Processing by Delta 9-Tetrahydrocannabinol and Cannabidiol . Int. J. Neuropsychopharmacol. 2010, 13, 421–432. DOI: 10.1017/S1461145709990617.
  • Rajesh, M.; Mukhopadhyay, P.; Bátkai, S.; Haskó, G.; Liaudet, L.; Drel, V. R.; Obrosova, I. G.; Pacher, P. Cannabidiol Attenuates High Glucose-Induced Endothelial Cell Inflammatory Response and Barrier Disruption. Am. J. Physiol. - Hear. Circ. Physiol. 2007, 293, 610–619. DOI: 10.1152/ajpheart.00236.2007.
  • Baek, S. H.; Kim, Y. O.; Kwag, J. S.; Choi, K. E.; Jung, W. Y.; Han, D. S. Boron Trifluoride Etherate on Silica-A Modified Lewis Acid Reagent (VII). Antitumor Activity of Cannabigerol against Human Oral Epitheloid Carcinoma Cells. Arch. Pharm. Res. 1998, 21, 353–356. DOI: 10.1007/BF02975301.
  • Tubaro, A.; Giangaspero, A.; Sosa, S.; Negri, R.; Grassi, G.; Casano, S.; Loggia, R.; Della; Appendino, G. Comparative Topical anti-Inflammatory Activity of Cannabinoids and Cannabivarins. Fitoterapia 2010, 81, 816–819. DOI: 10.1016/j.fitote.2010.04.009.
  • De Petrocellis, L.; Ligresti, A.; Moriello, A. S.; Allarà, M.; Bisogno, T.; Petrosino, S.; Stott, C. G.; Di Marzo, V. Effects of Cannabinoids and Cannabinoid-Enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes. Br. J. Pharmacol. 2011, 163, 1479–1494. DOI: 10.1111/j.1476-5381.2010.01166.x.
  • Dussy, F. E.; Hamberg, C.; Luginbühl, M.; Schwerzmann, T.; Briellmann, T. A. Isolation of Delta9-THCA-A from Hemp and Analytical Aspects Concerning the Determination of Delta9-THC in Cannabis Products. Forensic Sci. Int. 2005, 149, 3–10. DOI: 10.1016/j.forsciint.2004.05.015.
  • Zhuang, S. y.; Kittler, J.; Grigorenko, E. V.; Kirby, M. T.; Sim, L. J.; Hampson, R. E.; Childers, S. R.; Deadwyler, S. A. Effects of Long-Term Exposure to Δ9-THC on Expression of Cannabinoid Receptor (CB1) MRNA in Different Rat Brain Regions. Brain Res. Mol. Brain Res. 1998, 62, 141–149. DOI: 10.1016/S0169-328X(98)00232-0.
  • Abrahamov, A.; Abrahamov, A.; Mechoulam, R. An Efficient New Cannabinoid Antiemetic in Pediatric Oncology. Life Sci. 1995, Vol. 56. pp 2097–2102.
  • Hollister, L. E.; Gillespie, H. K. Delta-8- and Delta-9-Tetrahydrocannabinol Comparison in Man by Oral and Intravenous Administration. Clin. Pharmacol. Ther. 1973, 14, 353–357. DOI: 10.1002/cpt1973143353.
  • Moosmann, B.; Roth, N.; Auwärter, V. Hair Analysis for Δ9-Tetrahydrocannabinolic Acid A (THCA-A) and Δ9-Tetrahydrocannabinol (THC) after Handling Cannabis Plant Material. Drug Test. Anal. 2016, 8, 129–133. DOI: 10.1002/dta.1830..
  • De Petrocellis, L.; Ligresti, A.; Schiano Moriello, A.; Iappelli, M.; Verde, R.; Stott, C. G.; Cristino, L.; Orlando, P.; Di Marzo, V. Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth in Vitro and in Vivo: Pro-Apoptotic Effects and Underlying Mechanisms. Br. J. Pharmacol. 2013, 168, 79–102. DOI: 10.1111/j.1476-5381.2012.02027.x.
  • Sulak, D.; Saneto, R.; Goldstein, B. The Current Status of Artisanal Cannabis for the Treatment of Epilepsy in the United States. Epilepsy Behav. 2017, 70, 328–333. DOI: 10.1016/j.yebeh.2016.12.032.
  • Pertwee, R. G. Cannabinoid Pharmacology: The First 66 Years. Br. J. Pharmacol. 2006, 147. S163–S171. DOI: 10.1038/sj.bjp.0706406.
  • Gaynor, J. S.; Muir, W. W. Alternative Drugs and Novel Therapies Used to Treat Pain. Handb. Vet. Pain Manag. Third Ed , Vol. 1, Chapter 13, 2015, 280–301. DOI: 10.1016/B978-0-323-08935-7.00014-4.
  • Costa, B.; Colleoni, M.; Conti, S.; Parolaro, D.; Franke, C.; Trovato, A. E.; Giagnoni, G. Oral anti-Inflammatory Activity of Cannabidiol, a Non-Psychoactive Constituent of Cannabis, in Acute Carrageenan-Induced Inflammation in the Rat Paw. Naunyn. Schmiedebergs. Arch. Pharmacol. 2004, 369, 294–299. DOI: 10.1007/s00210-004-0871-3.
  • Sofia, R. D.; Vassar, H. B.; Knobloch, L. C. Comparative Analgesic Activity of Various Naturally Occurring Cannabinoids in Mice and Rats. Psychopharmacologia 1975, 40, 285–295. DOI: 10.1007/BF00421466.
  • Moreira, F. A.; Aguiar, D. C.; Guimarães, F. S. Anxiolytic-like Effect of Cannabidiol in the Rat Vogel Conflict Test. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006, 30, 1466–1471. DOI: 10.1016/j.pnpbp.2006.06.004.
  • Taura, F.; Morimoto, S.; Shoyama, Y. Purification and Characterization of Cannabidiolic-Acid Synthase from Cannabis sativa L. Biochemical Analysis of a Novel Enzyme that Catalyzes the Oxidocyclization of Cannabigerolic Acid to Cannabidiolic Acid. J. Biol. Chem. 1996, 271, 17411–17416. DOI: 10.1074/jbc.271.29.17411.
  • Takeda, S.; Okajima, S.; Miyoshi, H.; Yoshida, K.; Okamoto, Y.; Okada, T.; Amamoto, T.; Watanabe, K.; Omiecinski, C. J.; Aramaki, H. Cannabidiolic Acid, a Major Cannabinoid in Fiber-Type Cannabis, is an Inhibitor of MDA-MB-231 Breast Cancer Cell Migration. Toxicol. Lett. 2012, 214, 314–319. DOI: 10.1016/j.toxlet.2012.08.029.
  • Farkas, J.; Andrassy, E. The Sporostatic Effect of Cannabidiolic Acid. Appl. Life Sci 1976, 8, 57–67
  • Grunfeld, Y.; Edery, H. Psychopharmacological Activity of the Active Constituents of Hashish and Some Related Cannabinoids. Psychopharmacologia 1969, 14, 200–210. DOI: 10.1007/BF00404218.
  • Giacoppo, S.; Gugliandolo, A.; Trubiani, O.; Pollastro, F.; Grassi, G.; Bramanti, P.; Mazzon, E. Cannabinoid CB2 Receptors Are Involved in the Protection of RAW264.7 Macrophages against the Oxidative Stress: An in Vitro Study. Eur. J. Histochem 2017, 61, 1–13. DOI: 10.4081/ejh.2017.2749..
  • Wirth, P. W.; Watson, E. S.; ElSohly, M.; Turner, C. E.; Murphy, J. C. Anti-Inflammatory Properties of Cannabichromene. Life Sci. 1980, 26, 1991–1995. DOI: 10.1016/0024-3205(80)90631-1.
  • Turner, E.; ElSohly, M. Biological Activity of Cannabichromeniets, Homologs and Isomers. J. Clin. Pharmacol. 1981, 21.283S-291S
  • Romano, B.; Pagano, E.; Orlando, P.; Capasso, R.; Cascio, M. G.; Pertwee, R.; Marzo, V.; Di; Izzo, A. A.; Borrelli, F. Pure Δ9-Tetrahydrocannabivarin and a Cannabis Sativa Extract with High Content in Δ9-Tetrahydrocannabivarin Inhibit Nitrite Production in Murine Peritoneal Macrophages. Pharmacol. Res. 2016, 113, 199–208. DOI: 10.1016/j.phrs.2016.07.045.
  • Raffa, R. B.; Ward, S. J. CB₁-Independent Mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). J. Clin. Pharm. Ther. 2012, 37, 260–265. DOI: 10.1111/j.1365-2710.2011.01284.x.
  • Cawthorne, M.; Buckingham, (G. B.).; Stott, C.; Salisbury, (G. B.).; Stephen, W. S. (G.). (12) Patent Application Publication (10) Pub. No.: US 2014/0332121 A1 Eiongation (%) Patent Application Publication, 2014.
  • Englund, A.; Atakan, Z.; Kralj, A.; Tunstall, N.; Murray, R.; Morrison, P. The Effect of Five Day Dosing with THCV on THC-Induced Cognitive, Psychological and Physiological Effects in Healthy Male Human Volunteers: A Placebo-Controlled, Double-Blind, Crossover Pilot Trial. J. Psychopharmacol. 2016, 30, 140–151. DOI: 10.1177/0269881115615104.
  • Futamura, D. W. W. S. (12) Patent Application Publication. (10) Pub. No.: US 2015/0258769 A1 Lifted-off Layer Patent Application Publication. US20150320698A1, 2015.
  • Di Marco Pisciottano, I.; Guadagnuolo, G.; Soprano, V.; De Crescenzo, M.; Gallo, P. A Rapid Method to Determine Nine Natural Cannabinoids in Beverages and Food Derived from Cannabis Sativa by Liquid Chromatography Coupled to Tandem Mass Spectrometry on a QTRAP 4000. Rapid Commun. Mass Spectrom. 2018, 32, 1728–1736. DOI: 10.1002/rcm.8242.
  • Pellegrini, M.; Marchei, E.; Pacifici, R.; Pichini, S. A Rapid and Simple Procedure for the Determination of Cannabinoids in Hemp Food Products by Gas Chromatography-Mass Spectrometry. J. Pharm. Biomed. Anal. 2005, 36, 939–946. DOI: 10.1016/j.jpba.2004.07.035.
  • Lachenmeier, D. W.; Kroener, L.; Musshoff, F.; Madea, B. Determination of Cannabinoids in Hemp Food Products by Use of Headspace Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry. Anal. Bioanal. Chem. 2004, 378, 183–189. DOI: 10.1007/s00216-003-2268-4.
  • Ramirez, C. L.; Fanovich, M. A.; Churio, M. S. Cannabinoids: Extraction Methods, Analysis, and Physicochemical Characterization. In Studies in Natural Products Chemistry; Elsevier B.V.: Amsterdam, The Netherlands. 2018; Vol. 61, pp 143–173. DOI: 10.1016/B978-0-444-64183-0.00004-X.
  • Pegoraro, C. N.; Nutter, D.; Thevenon, M.; Ramirez, C. L. Chemical Profiles of Cannabis Sativa Medicinal Oil Using Different Extraction and Concentration Methods. Nat. Prod. Res., Vol. 35, 2019, 1–4. DOI: 10.1080/14786419.2019.1663515.
  • Deidda, R.; Avohou, H. T.; Baronti, R.; Davolio, P. L.; Pasquini, B.; Del Bubba, M.; Hubert, C.; Hubert, P.; Orlandini, S.; Furlanetto, S. Analytical Quality by Design: Development and Control Strategy for a LC Method to Evaluate the Cannabinoids Content in Cannabis Olive Oil Extracts. J. Pharm. Biomed. Anal. 2019, 166, 326–335. DOI: 10.1016/j.jpba.2019.01.032.
  • Chang, C. W.; Tung, C. W.; Tsai, C. C.; Wu, Y. T.; Hsu, M. C. Determination of Cannabinoids in Hemp Nut Products in Taiwan by HPLC-MS/MS Coupled with Chemometric Analysis: Quality Evaluation and a Pilot Human Study. Drug Test Anal. 2017, 9, 888–897. DOI: 10.1002/dta.2062.
  • Hazekamp, A.; Romano, L. L. Cannabis Oil: Chemical Evaluation of an Upcoming Cannabis-Based Medicine. Cannabinoids 2013, 1, 1–11.
  • De Backer, B.; Debrus, B.; Lebrun, P.; Theunis, L.; Dubois, N.; Decock, L.; Verstraete, A.; Hubert, P.; Charlier, C. Innovative Development and Validation of an HPLC/DAD Method for the Qualitative and Quantitative Determination of Major Cannabinoids in Cannabis Plant Material. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2009, 877, 4115–4124. DOI: 10.1016/j.jchromb.2009.11.004.
  • Rovetto, L. J.; Aieta, N. V. Supercritical Carbon Dioxide Extraction of Cannabinoids from Cannabis Sativa L. J. Supercrit. Fluids 2017, 129, 16–27. DOI: 10.1016/j.supflu.2017.03.014.
  • Brighenti, V.; Pellati, F.; Steinbach, M.; Maran, D.; Benvenuti, S. Development of a New Extraction Technique and HPLC Method for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis Sativa L. (Hemp). J. Pharm. Biomed. Anal. 2017, 143, 228–236. DOI: 10.1016/j.jpba.2017.05.049.
  • Giese, M. W.; Lewis, M. A.; Giese, L.; Smith, K. M. Development and Validation of a Reliable and Robust Method for the Analysis of Cannabinoids and Terpenes in Cannabis. J. Aoac Int. 2015, 98, 1503–1522. DOI: 10.5740/jaoacint.15-116.
  • Mudge, E. M.; Murch, S. J.; Brown, P. N. Leaner and Greener Analysis of Cannabinoids. Anal. Bioanal. Chem. 2017, 409, 3153–3163. DOI: 10.1007/s00216-017-0256-3.
  • Mandrioli, M.; Tura, M.; Scotti, S.; Toschi, T. G. Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in Cannabis Sativa L. Molecules 2019, 24, 2113–2112. DOI: 10.3390/molecules24112113.
  • Deville, M.; Dubois, N.; Denooz, R.; Charlier, C. Validation of an UHPLC/DAD Method for the Determination of Cannabinoids in Seized Materials : Analysis of 213 Samples Sold in Belgian CBD shops. Forensic Sci. Int. 2020, 310, 110234. DOI: 10.1016/j.forsciint.2020.110234.
  • Ciolino, L. A.; Ranieri, T. L.; Taylor, A. M. Commercial Cannabis Consumer Products Part 2: HPLC-DAD Quantitative Analysis of Cannabis Cannabinoids. Forensic Sci. Int. 2018, 289, 438–447. DOI: 10.1016/j.forsciint.2018.05.033.
  • Wang, Y. H.; Avula, B.; Elsohly, M. A.; Radwan, M. M.; Wang, M.; Wanas, A. S.; Mehmedic, Z.; Khan, I. A. Quantitative Determination of Δ9-THC, CBG, CBD, Their Acid Precursors and Five Other Neutral Cannabinoids by UHPLC-UV-MS. Planta Med. 2018, 84, 260–266. DOI: 10.1055/s-0043-124873.
  • Wang, M.; Wang, Y. H.; Avula, B.; Radwan, M. M.; Wanas, A. S.; Mehmedic, Z.; van Antwerp, J.; ElSohly, M. A.; Khan, I. A. Quantitative Determination of Cannabinoids in Cannabis and Cannabis Products Using Ultra-High-Performance Supercritical Fluid Chromatography and Diode Array/Mass Spectrometric Detection. J. Forensic Sci. 2017, 62, 602–611. DOI: 10.1111/1556-4029.13341.
  • Elisabeth, K.; Krönert, S.; Broillet, A.; Weinmann, W.; Gmbh, M. J.; Gmbh, M. J. Cannabidiol and Tetrahydrocannabinol Concentrations in Commercially Available CBD E-Liquids in Switzerland. Forensic Sci. Int 2020, 310., 0379-0738 DOI: 10.1016/j.forsciint.2020.110261.
  • Aizpurua-Olaizola, O.; Omar, J.; Navarro, P.; Olivares, M.; Etxebarria, N.; Usobiaga, A. Identification and Quantification of Cannabinoids in Cannabis Sativa L. Plants by High Performance Liquid Chromatography-Mass Spectrometry. Anal. Bioanal. Chem. 2014, 406, 7549–7560. DOI: 10.1007/s00216-014-8177-x.
  • Calvi, L.; Pentimalli, D.; Panseri, S.; Giupponi, L.; Gelmini, F.; Beretta, G.; Vitali, D.; Bruno, M.; Zilio, E.; Pavlovic, R.; Giorgi, A. Comprehensive Quality Evaluation of Medical Cannabis Sativa L. Inflorescence and Macerated Oils Based on HS-SPME Coupled to GC-MS and LC-HRMS (q-exactive orbitrap®) approach. J. Pharm. Biomed. Anal. 2018, 150, 208–219. DOI: 10.1016/j.jpba.2017.11.073.
  • Carcieri, C.; Tomasello, C.; Simiele, M.; De Nicolò, A.; Avataneo, V.; Canzoneri, L.; Cusato, J.; Di Perri, G.; D’Avolio, A. Cannabinoids Concentration Variability in Cannabis Olive Oil Galenic Preparations. J. Pharm. Pharmacol. 2018, 70, 143–149. DOI: 10.1111/jphp.12845.
  • Christinat, N.; Savoy, M. C.; Mottier, P. Development, Validation and Application of a LC-MS/MS Method for Quantification of 15 Cannabinoids in Food. Food Chem. 2020, 318, (October 2019), 126469. DOI: 10.1016/j.foodchem.2020.126469.
  • Agarwal, C.; Máthé, K.; Hofmann, T.; Csóka, L. Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa L. Optimized by Response Surface Methodology. J. Food Sci. 2018, 83, 700–710. DOI: 10.1111/1750-3841.14075.
  • Stolker, A. A. M.; van Schoonhoven, J.; de Vries, A. J.; Bobeldijk-Pastorova, I.; Vaes, W. H. J.; van den Berg, R. Determination of Cannabinoids in Cannabis Products Using Liquid Chromatography-Ion Trap Mass Spectrometry. J. Chromatogr. A. 2004, 1058, 143–151. DOI: 10.1016/j.chroma.2004.08.089.
  • Lewis-Bakker, M. M.; Yang, Y.; Vyawahare, R.; Kotra, L. P. Extractions of Medical Cannabis Cultivars and the Role of Decarboxylation in Optimal Receptor Responses. Cannabis Cannabinoid Res. 2019, 4, 183–194. DOI: 10.1089/can.2018.0067.
  • Protti, M.; Brighenti, V.; Battaglia, M. R.; Anceschi, L.; Pellati, F.; Mercolini, L. Cannabinoids from Cannabis Sativa L.: a New Tool Based on HPLC-DAD-MS/MS for a Rational Use in Medicinal Chemistry. ACS Med. Chem. Lett. 2019, 10, 539–544. DOI: 10.1021/acsmedchemlett.8b00571.
  • Citti, C.; Ciccarella, G.; Braghiroli, D.; Parenti, C.; Vandelli, M. A.; Cannazza, G. Medicinal Cannabis: Principal Cannabinoids Concentration and Their Stability Evaluated by a High Performance Liquid Chromatography Coupled to Diode Array and Quadrupole Time of Flight Mass Spectrometry Method. J. Pharm. Biomed. Anal. 2016, 128, 201–209. DOI: 10.1016/j.jpba.2016.05.033.
  • Fiorini, D.; Molle, A.; Nabissi, M.; Santini, G.; Benelli, G.; Maggi, F. Valorizing Industrial Hemp (Cannabis Sativa L.) by-Products: Cannabidiol Enrichment in the Inflorescence Essential Oil Optimizing Sample Pre-Treatment Prior to Distillation. Ind. Crops Prod. 2019, 128, 581–589. DOI: 10.1016/j.indcrop.2018.10.045.
  • Casiraghi, A.; Roda, G.; Casagni, E.; Cristina, C.; Musazzi, U. M.; Franzè, S.; Rocco, P.; Giuliani, C.; Fico, G.; Minghetti, P.; Gambaro, V. Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations. Planta Med. 2018, 84, 242–249. DOI: 10.1055/s-0043-123074.
  • Wianowska, D.; Dawidowicz, A. L.; Kowalczyk, M. Transformations of Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Cannabinol during Their Extraction from Cannabis Sativa L. J. Anal. Chem. 2015, 70, 920–925. DOI: 10.1134/S1061934815080183.
  • Omar, J.; Olivares, M.; Alzaga, M.; Etxebarria, N. Optimisation and Characterisation of Marihuana Extracts Obtained by Supercritical Fluid Extraction and Focused Ultrasound Extraction and Retention Time Locking GC-MS. J. Sep. Sci. 2013, 36, 1397–1404. DOI: 10.1002/jssc.201201103.
  • Hewavitharana, A. K.; Golding, G.; Tempany, G.; King, G.; Holling, N. Quantitative GC-MS Analysis of D(9)-Tetrahydrocannabinol in Fiber Hemp Varieties . J. Anal. Toxicol. 2005, 29, 258–261. DOI: 10.1093/jat/29.4.258.
  • Cardenia, V.; Gallina Toschi, T.; Scappini, S.; Rubino, R. C.; Rodriguez-Estrada, M. T. Development and Validation of a Fast Gas Chromatography/Mass Spectrometry Method for the Determination of Cannabinoids in Cannabis Sativa L. J. Food Drug Anal. 2018, 26, 1283–1292. DOI: 10.1016/j.jfda.2018.06.001.
  • Mariotti, K. d C.; Marcelo, M. C. A.; Ortiz, R. S.; Borille, B. T.; dos Reis, M.; Fett, M. S.; Ferrão, M. F.; Limberger, R. P. Seized Cannabis Seeds Cultivated in Greenhouse: A Chemical Study by Gas Chromatography-Mass Spectrometry and Chemometric Analysis. Sci. Justice 2016, 56, 35–41. DOI: 10.1016/j.scijus.2015.09.002.
  • Fischedick, J. T.; Hazekamp, A.; Erkelens, T.; Choi, Y. H.; Verpoorte, R. Metabolic Fingerprinting of Cannabis Sativa L., Cannabinoids and Terpenoids for Chemotaxonomic and Drug Standardization Purposes. Phytochemistry 2010, 71, 2058–2073. DOI: 10.1016/j.phytochem.2010.10.001.
  • Brunetti, P.; Pichini, S.; Pacifici, R.; Busardò, F. P.; del Rio, A. Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors. Med 2020, 56, 237–215. DOI: 10.3390/medicina56050237.
  • Borges, G. R.; Birk, L.; Scheid, C.; Morés, L.; Carasek, E.; Kitamura, R. O. S.; Roveri, F. L.; Eller, S.; de Oliveira Merib, J.; de Oliveira, T. F. Simple and Straightforward Analysis of Cannabinoids in Medicinal Products by Fast-GC–FID. Forensic Toxicol. 2020, 38, 531–535. DOI: 10.1007/s11419-020-00522-1.
  • Bosy, T. Z.; Cole, K. A. Consumption and Quantitation of delta9-tetrahydrocannabinol in Commercially Available Hemp Seed Oil Products. J. Anal. Toxicol. 2000, 24, 562–566. DOI: 10.1093/jat/24.7.562.
  • Petrović, M.; Debeljak, Ž.; Kezić, N.; Džidara, P. Relationship between Cannabinoids Content and Composition of Fatty Acids in Hempseed Oils. Food Chem. 2015, 170, 218–225. DOI: 10.1016/j.foodchem.2014.08.039.
  • Pacifici, R.; Marchei, E.; Salvatore, F.; Guandalini, L.; Busardò, F. P.; Pichini, S. Evaluation of Cannabinoids Concentration and Stability in Standardized Preparations of Cannabis Tea and Cannabis Oil by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. Clin. Chem. Lab. Med. 2017, 55, 1555–1563. DOI: 10.1515/cclm-2016-1060.
  • Fekete, S.; Sadat-Noorbakhsh, V.; Schelling, C.; Molnár, I.; Guillarme, D.; Rudaz, S.; Veuthey, J. L. Implementation of a Generic Liquid Chromatographic Method Development Workflow: Application to the Analysis of Phytocannabinoids and Cannabis Sativa Extracts. J. Pharm. Biomed. Anal. 2018, 155, 116–124. DOI: 10.1016/j.jpba.2018.03.059.
  • Hewavitharana, A. K.; Golding, G.; Tempany, G.; King, G.; Holling, N. Quantitative GC-MS Analysis of Ag-Tetrahydrocannabinol in Fiber Hemp Varieties; Journal of Analytical Toxicology, Oxford Academic 2005, Vol. 29., 258–261.
  • Paiva, A.; Craveiro, R.; Aroso, I.; Martins, M.; Reis, R. L.; Duarte, A. R. C. Natural Deep Eutectic Solvents - Solvents for the 21st Century. ACS Sustainable Chem. Eng. 2014, 2, 1063–1071. DOI: 10.1021/sc500096j.
  • Křížek, T.; Bursová, M.; Horsley, R.; Kuchař, M.; Tůma, P.; Čabala, R.; Hložek, T. Menthol-Based Hydrophobic Deep Eutectic Solvents: Towards Greener and Efficient Extraction of Phytocannabinoids. J. Clean. Prod 2018, 193, 391–396. DOI: 10.1016/j.jclepro.2018.05.080.
  • Chang, C. W.; Yen, C. C.; Wu, M. T.; Hsu, M. C.; Wu, T. Y. Microwave-Assisted Extraction of Cannabinoids in Hemp Nut Using Response Surface Methodology: Optimization and Comparative Study. Molecules 2017, 22, 1894–1815. DOI: 10.3390/molecules22111894.
  • Bimakr, M.; Rahman, R. A.; Taip, F. S.; Ganjloo, A.; Salleh, L. M.; Selamat, J.; Hamid, A.; Zaidul, I. S. M. Comparison of Different Extraction Methods for the Extraction of Major Bioactive Flavonoid Compounds from Spearmint (Mentha Spicata L.) Leaves. Food Bioprod. Process 2011, 89, 67–72. DOI: 10.1016/j.fbp.2010.03.002.
  • Delgado-Povedano, M. M.; Sánchez-Carnerero Callado, C.; Priego-Capote, F.; Ferreiro-Vera, C. Untargeted Characterization of Extracts from Cannabis Sativa L. Cultivars by Gas and Liquid Chromatography Coupled to Mass Spectrometry in High Resolution Mode. Talanta 2020, 208, 120384. DOI: 10.1016/j.talanta.2019.120384.
  • Patnala, P. K.; Tilvi, S.; Srivastava, P. Experimental and Kinetic Studies on the Combined Influence of Ultrasonication and Rare Earths on Removal of Azo Dyes. Sep. Sci. Technol. 2019, 54, 1632–1649. DOI: 10.1080/01496395.2018.1549571.
  • Srivastava, P.; Goyal, S.; Patnala, P. K. Degradation of Reactive, Acid and Basic Textile Dyes in the Presence of Ultrasound and Rare Earths [Lanthanum and Praseodymium]. Ultrason. Sonochem 2014, 21,1994–2009. DOI: 10.1016/j.ultsonch.2014.01.016.
  • Ghafoor, M.; Misra, N. N.; Mahadevan, K.; Tiwari, B. K. Ultrasound Assisted Hydration of Navy Beans (Phaseolus Vulgaris). Ultrason. Sonochem. 2014, 21, 409–414. DOI: 10.1016/j.ultsonch.2013.05.016.
  • Kelkar, M. A.; Gogate, P. R.; Pandit, A. B. Intensification of Esterification of Acids for Synthesis of Biodiesel Using Acoustic and Hydrodynamic Cavitation. Ultrason. Sonochem. 2008, 15, 188–194. DOI: 10.1016/j.ultsonch.2007.04.003.
  • De Vita, D.; Madia, V. N.; Tudino, V.; Saccoliti, F.; De Leo, A.; Messore, A.; Roscilli, P.; Botto, A.; Pindinello, I.; Santilli, G. Comparison of Different Methods for the Extraction of Cannabinoids from Cannabis. Nat. Prod. Res 2019, 0, 1–7. DOI: 10.1080/14786419.2019.1601194.
  • Chan, C. H.; Yusoff, R.; Ngoh, G. C.; Kung, F. W. L. Microwave-Assisted Extractions of Active Ingredients from Plants. J. Chromatogr. A. 2011, 1218, 6213–6225. DOI: 10.1016/j.chroma.2011.07.040.
  • Drinić, Z.; Vladić, J.; Koren, A.; Zeremski, T.; Stojanov, N.; Kiprovski, B.; Vidović, S. Microwave‐Assisted Extraction of Cannabinoids and Antioxidants from Cannabis Sativa Aerial Parts and Process Modeling. J. Chem. Technol. Biotechnol., 2020, 95, 831–839. DOI: 10.1002/jctb.6273.
  • De Melo, M. M. R.; Silvestre, A. J. D.; Silva, C. M. Supercritical Fluid Extraction of Vegetable Matrices: Applications, Trends and Future Perspectives of a Convincing Green Technology. J. Supercrit. Fluids 2014, 92, 115–176. DOI: 10.1016/j.supflu.2014.04.007.
  • Citti, C.; Braghiroli, D.; Vandelli, M. A.; Cannazza, G. Pharmaceutical and Biomedical Analysis of Cannabinoids: A Critical Review. J. Pharm. Biomed. Anal. 2018, 147, 565–579. DOI: 10.1016/j.jpba.2017.06.003.
  • Elkins, A. C.; Deseo, M. A.; Rochfort, S.; Ezernieks, V.; Spangenberg, G. Development of a Validated Method for the Qualitative and Quantitative Analysis of Cannabinoids in Plant Biomass and Medicinal Cannabis Resin Extracts Obtained by Super-Critical Fluid Extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2019, 1109, 76–83. DOI: 10.1016/j.jchromb.2019.01.027.
  • Perrotin-Brunel, H.; Perez, P. C.; van Roosmalen, M. J. E.; van Spronsen, J.; Witkamp, G. J.; Peters, C. J. Solubility of Δ9-Tetrahydrocannabinol in Supercritical Carbon Dioxide: Experiments and Modeling. J. Supercrit. Fluids 2010, 52, 6–10. DOI: 10.1016/j.supflu.2009.12.001.
  • Grijó, D. R.; Vieitez Osorio, I. A.; Cardozo-Filho, L. Supercritical Extraction Strategies Using CO 2 and Ethanol to Obtain Cannabinoid Compounds from Cannabis Hybrid Flowers. J. CO2 Util 2018, 28, 174–180. DOI: 10.1016/j.jcou.2018.09.022.
  • Wang, M.; Wang, Y. H.; Avula, B.; Radwan, M. M.; Wanas, A. S.; Van Antwerp, J.; Parcher, J. F.; Elsohly, M. A.; Khan, I. A. Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis Cannabinoid Res. 2016, 1, 262–271. DOI: 10.1089/can.2016.0020.
  • Tose, L. V.; Murgu, M.; Kuster, R. M.; Ortiz, R. S.; Camargo, F. A. O.; Vaz, B. G. Analysis of Isomeric Cannabinoid Standards and J. Braz. Chem. Soc. 2019, 30, 60–70.
  • Citti, C.; Battisti, U. M.; Braghiroli, D.; Ciccarella, G.; Schmid, M.; Vandelli, M. A.; Cannazza, G. A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts. Phytochem. Anal. 2018, 29, 144–155. DOI: 10.1002/pca.2722.
  • De Brabanter, N.; Van Gansbeke, W.; Hooghe, F.; Van Eenoo, P. Fast Quantification of 11-nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid (THCA) Using Microwave-Accelerated Derivatisation and Gas Chromatography-Triple Quadrupole Mass Spectrometry. Forensic Sci. Int. 2013, 224, 90–95. DOI: 10.1016/j.forsciint.2012.11.004.
  • Hädener, M.; König, S.; Weinmann, W. Quantitative Determination of CBD and THC and Their Acid Precursors in Confiscated Cannabis Samples by HPLC-DAD. Forensic Sci. Int. 2019, 299, 142–150. DOI: 10.1016/j.forsciint.2019.03.046.
  • Cappelletto, P.; Brizzi, M.; Mongardini, F.; Barberi, B.; Sannibale, M.; Nenci, G.; Poli, M.; Corsi, G.; Grassi, G.; Pasini, P. Italy-Grown Hemp: Yield, Composition and Cannabinoid Content. Ind. Crops Prod. 2001, 13, 101–113. DOI: 10.1016/S0926-6690(00)00057-1.
  • Raharjo, T. J.; Verpoorte, R. Methods for the Analysis of Cannabinoids in Biological Materials: A Review. Phytochem. Anal. 2004, 15, 79–94. DOI: 10.1002/pca.753.
  • Hazekamp, A.; Simons, R.; Peltenburg-Looman, A.; Sengers, M.; Van Zweden, R.; Verpoorte, R. Preparative Isolation of Cannabinoids from Cannabis Sativa by Centrifugal Partition Chromatography. J. Liq. Chromatogr. Relat. Technol 2004, 27, 2421–2439. DOI: 10.1081/JLC-200028170.
  • Popp, J. R.; Petrakis, E. A.; Angelis, A.; Halabalaki, M.; Bonn, G. K.; Stuppner, H.; Skaltsounis, L. A. Rapid Isolation of Acidic Cannabinoids from Cannabis Sativa L. Using PH-Zone-Refining Centrifugal Partition Chromatography. J. Chromatogr. A. 2019, 1599, 196–202. DOI: 10.1016/j.chroma.2019.04.048.
  • Galand, N.; Ernouf, D.; Montigny, F.; Dollet, J.; Pothier, J. Separation and Identification of Cannabis Components by Different Planar Chromatography Techniques (TLC, AMD, OPLC). J. Chromatogr. Sci. 2004, 42, 130–134. DOI: 10.1093/chromsci/42.3.130.
  • Fischedick, J. T.; Glas, R.; Hazekamp, A.; Verpoorte, R. A Qualitative and Quantitative HPTLC Densitometry Method for the Analysis of Cannabinoids in Cannabis Sativa L. Phytochem. Anal. 2009, 20, 421–426. DOI: 10.1002/pca.1143.
  • Hazekamp, A.; Peltenburg, A.; Verpoorte, R.; Giroud, C. Chromatographic and Spectroscopic Data of Cannabinoids from Cannabis Sativa L. J. Liq. Chromatogr. Relat. Technol 2005, 28, 2361–2382. DOI: 10.1080/10826070500187558.
  • Zoller, O.; Rhyn, P.; Zimmerli, B. High-Performance Liquid Chromatographic Determination of Δ9- Tetrahydrocannabinol and the Corresponding Acid in Hemp Containing Foods with Special Regard to the Fluorescence Properties of Δ9-Tetrahydrocannabinol. J. Chromatogr. A. 2000, 872, 101–110. DOI: 10.1016/S0021-9673(99)01287-X.
  • Noestheden, M.; Friedlander, G.; Anspach, J.; Krepich, S.; Hyland, K. C.; Zandberg, W. F. Chromatographic Characterisation of 11 Phytocannabinoids: Quantitative and Fit-to-Purpose Performance as a Function of Extra-Column Variance. Phytochem. Anal. 2018, 29, 507–515. DOI: 10.1002/pca.2761.
  • Orlowicz, S.; Krepich, S. 16 cannabinoids for Potency testing by practical LC-UV https://www.phenomenex.com/ViewDocument/?id=16+cannabinoids+for+potency+testing+by+practical+lc-uv.
  • Parasuraman, S.; Rao, A.; Balamurugan, S.; Muralidharan, S.; Jayaraj Kumar, K.; Vijayan, V. An Overview of Liquid Chromatography-Mass Spectroscopy Instrumentation., Pharmaceutical Technology Pharm. Methods 5, 47–55, 2014. DOI: 10.5530/phm.2014.2.2..
  • CrawfordScientific. https://live.chromacademy.com/channels/lc-ms/instrumentation/introduction-to-mass-analyzers/. accessed on 13/07/2021
  • De Vos, R. C. H.; Moco, S.; Lommen, A.; Keurentjes, J. J. B.; Bino, R. J.; Hall, R. D. Untargeted Large-Scale Plant Metabolomics Using Liquid Chromatography Coupled to Mass Spectrometry. Nat. Protoc. 2007, 2, 778–791. DOI: 10.1038/nprot.2007.95.
  • Broecker, S.; Pragst, F. Isomerization of Cannabidiol and Δ9-Tetrahydrocannabinol During Positive Electrospray Ionization. In-Source Hydrogen/Deuterium Exchange Experiments by Flow Injection Hybrid Quadrupole-Time-of-Flight Mass Spectrometry. Rapid Commun Mass Spectrom 2012, 26, 1407–1414. DOI: 10.1002/rcm.6244.
  • Abd-Elsalam, W. H.; Alsherbiny, M. A.; Kung, J. Y.; Pate, D. W.; Löbenberg, R. LC-MS/MS Quantitation of Phytocannabinoids and Their Metabolites in Biological Matrices. Talanta 2019, 204, 846–867. DOI: 10.1016/j.talanta.2019.06.053.
  • Pichini, S.; Mannocchi, G.; Gottardi, M.; Pérez-Acevedo, A. P.; Poyatos, L.; Papaseit, E.; Pérez-Mañá, C.; Farré, M.; Pacifici, R.; Busardò, F. P. Fast and Sensitive UHPLC-MS/MS Analysis of Cannabinoids and Their Acid Precursors in Pharmaceutical Preparations of Medical Cannabis and Their Metabolites in Conventional and Non-Conventional Biological Matrices of Treated Individual. Talanta 2020, 209, 120537. DOI: 10.1016/j.talanta.2019.120537.
  • Leiman, K.; Colomo, L.; Armenta, S.; de la Guardia, M.; Esteve-Turrillas, F. A. Fast Extraction of Cannabinoids in Marijuana Samples by Using Hard-Cap Espresso Machines. Talanta 2018, 190, 321–326. DOI: 10.1016/j.talanta.2018.08.009.
  • Shoyama, Y.; Yagi, M.; Nishioka, I.; Yamauchi, T. Biosynthesis of Cannabinoid Acids. Phytochemistry 1975, 14, 2189–2192. DOI: 10.1016/S0031-9422(00)91096-3.
  • Harvey, D. J. Cyclic Alkylboronates as Derivatives for the Characterization of Cannabinolic Acids by Combined Gas Chromatography and Mass Spectrometry. Biol. Mass Spectrom. 1977, 4, 88–93. 10.1002/bms.1200040206. DOI: 10.1002/bms.1200040206.
  • Coles, R.; Clements, T. T.; Nelson, G. J.; McMillin, G. A.; Urry, F. M. Simultaneous Analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC-MS. J. Anal. Toxicol. 2005, 29, 522–527. DOI: 10.1093/jat/29.6.522.
  • Gambaro, V.; Dell’Acqua, L.; Farè, F.; Froldi, R.; Saligari, E.; Tassoni, G. Determination of Primary Active Constituents in Cannabis Preparations by High-Resolution Gas Chromatography/Flame Ionization Detection and High-Performance Liquid Chromatography/UV Detection. Anal. Chim. Acta 2002, 468, 245–254. DOI: 10.1016/S0003-2670(02)00660-8.
  • Pacifici, R.; Marchei, E.; Salvatore, F.; Guandalini, L.; Busardò, F. P.; Pichini, S. Stability of Cannabinoids in Cannabis FM1 Flowering Tops and Oil Preparation Evaluated by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. Clin. Chem. Lab. Med. 2019, 57, e165–e168. DOI: 10.1515/cclm-2018-1145.
  • Kilmer, B. New Developments in Cannabis Regulation. Heal. Soc. respones to Drug Probl. a Eur. Guid 2017, 1, 1–25.
  • Brendan Hughes, Cannabis Legislation in Europe, Legal Notice, European Monitoring Centre for Drugs and Drug Addiction. Publication office of European Union, Luxembourg, 2, 1-30, 2018. DOI: 10.1007/978-3-642-16248-0_32.
  • Bradshaw, S. Misuse of Drugs Act 1971. Br. Med. J. 1971, 4, 363. DOI: 10.1136/bmj.4.5783.363-b.
  • Statutory Instrument, S.I, N173 of 2017 Misuse of Drugs Regulations, The office of Athrney general, Republic of Ireland, Dublin, Vollume 1 parts 1-6, Pages 2-59, 2017, 173.
  • Lampe, J. R.; Attorney, L. The Controlled Substances Act (CSA): a Legal Overview for the 116th Congress. Congr. Res. Serv. Rep 2019, Volume 1, 1–30.
  • Mechoulam, R.; Mccallum, N. K.; Burstein, S. Recent Advances in the Chemistry and Biochemistry of Cannabis. Chem. Rev. 1976, 76, 75–112. DOI: 10.1021/cr60299a002.
  • THE EUROPEAN COMMISSION. COMMISSION RECOMMENDATION (EU) 2016/2115 on the Monitoring of the Presence of Δ9-Tetrahydrocannabinol, Its Precursors and Other Cannabinoids in Food. Official Journal of the European Union 2016, DOI: 10.2903/j.efsa.2015.4141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.